Production (Stage)
Crinetics Pharmaceuticals, Inc.
CRNX
$31.17
-$0.5962-1.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.27B | 1.35B | 862.67M | 862.95M | 900.96M |
| Total Receivables | 7.31M | 8.47M | 6.94M | 4.98M | 9.33M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.25M | 10.43M | 6.10M | 4.31M | 2.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.37M | 2.42M | 1.88M | 2.54M | 4.11M |
| Total Current Assets | 1.29B | 1.38B | 877.59M | 874.78M | 917.23M |
|
|
|||||
| Total Current Assets | 1.29B | 1.38B | 877.59M | 874.78M | 917.23M |
| Net Property, Plant & Equipment | 55.32M | 55.58M | 55.98M | 57.26M | 57.63M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.95M | 1.63M | 1.81M | 1.50M | 1.30M |
| Total Assets | 1.36B | 1.43B | 937.37M | 935.54M | 978.15M |
|
|
|||||
| Total Accounts Payable | 9.84M | 5.85M | 4.94M | 8.87M | 10.76M |
| Total Accrued Expenses | 38.38M | 44.49M | 39.28M | 35.48M | 29.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.88M | 7.15M | 7.41M | 7.45M | 5.79M |
| Total Finance Division Other Current Liabilities | 2.21M | 2.19M | 1.93M | 2.58M | 5.39M |
| Total Other Current Liabilities | 2.21M | 2.19M | 1.93M | 2.58M | 5.39M |
| Total Current Liabilities | 57.31M | 59.68M | 53.56M | 54.38M | 51.77M |
|
|
|||||
| Total Current Liabilities | 57.31M | 59.68M | 53.56M | 54.38M | 51.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 43.94M | 44.57M | 45.13M | 45.87M | 46.71M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.08M | 5.53M | 5.71M | 4.52M | 4.74M |
| Total Liabilities | 107.33M | 109.79M | 104.39M | 104.77M | 103.22M |
|
|
|||||
| Common Stock & APIC | 2.30B | 2.28B | 1.70B | 1.63B | 1.60B |
| Retained Earnings | -1.05B | -952.11M | -871.52M | -794.69M | -720.63M |
| Treasury Stock & Other | 2.00M | 963.00K | 2.04M | -190.00K | 150.00K |
| Total Common Equity | 1.25B | 1.32B | 832.98M | 830.76M | 874.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.25B | 1.32B | 832.98M | 830.76M | 874.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.25B | 1.32B | 832.98M | 830.76M | 874.93M |
|
|
|||||